艾美捷科技代理Scripps Laboratories 品牌。

Scripps Laboratories 是一家专注于生物化学试剂和免疫分析产品的公司，提供高质量的抗体、酶、蛋白质和免疫分析试剂盒，支持生命科学研究和临床诊断。Scripps Laboratories公司采用先进的生产和质控技术，确保产品的高质量和一致性；用于免疫学、细胞生物学和分子生物学研究；疾病诊断、生物标志物检测和健康监测；药物筛选、药效评估和毒性测试；生物制药、疫苗开发和生物材料研究。

Scripps Laboratories主要产品与服务包括：

（1）抗体：提供多种高特异性和高灵敏度的抗体，用于免疫学研究和诊断。

（2）酶和蛋白质：提供多种高纯度的酶和蛋白质，用于生物化学和分子生物学研究。

（3）免疫分析试剂盒：提供多种免疫分析试剂盒，包括 ELISA 试剂盒、蛋白质印迹试剂和细胞分析试剂。

（4）定制服务:根据客户需求，提供定制化的抗体和免疫分析试剂开发服务。

艾美捷科技特约代理CovaChem公司产品。

CovaChem公司致力于为生命科学领域的科学家提供化学产品。主要涉及的领域是质谱、蛋白质组学、蛋白质科学、药物测试及药物筛选。

CovaChem is a chemical manufacturing company serving research scientists in the life sciences. We are dedicated to producing the highest quality reagents in the marketplace for use in mass spectrometry, proteomics, protein sciences, drug testing and drug development. We offer a wide range of products in both small scale and bulk quantities. For sizes larger than our catalog offering, please contact us for a custom quotation. CovaChem is proud to serve customers around the world, with their chemical, biotech, and analytical product needs. The customer is always our top priority, and this is why we offer an UNCONDITIONAL GUARANTEE for all of our products!

CovaChem的主要产品包括：

Protein Crosslinkers

LCMS & HPLC Mobile Phases

Protein Modifiers

GC Derivatization Reagents

Chemicals

MALDI Matrices

Buffers & Solvents

Beta Glucuronidase

艾美捷科技特约代理BioPorto Diagnostics A/S公司产品。

BioPorto Diagnostics A/S公司成立于2001年，是丹麦一家专门生产抗体和基于抗体的各种生物产品的公司。BioPorto拥有Bioporto Diagnostics和Antibodyshop两个品牌，分别侧重于诊断试剂盒和抗体产品。在30多个国家有代理商，产品销售网络遍布全球，99%以上为出口销售。BioPorto Diagnostics旗下产品主要为几种临床快速诊断试剂盒，包括诊断早期急性肾损伤的NGAL ELISA kit，Gc-globulin ELISA kit ，评估原发性免疫缺陷的MBL Oligomer ELISA kit，同时还有相关其他种属的科研用试剂盒和抗原抗体。其最新推出的产品有检测人体血浆中的活性蛋白C-蛋白C抑制物(APC-PCI)复合物的APC-PCI ELISA kit，高纯度人IgE单克隆抗体，以及Glucagon-like peptide-1和Exendin-4相关的单抗。

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.